449
Participants
Start Date
May 31, 2012
Primary Completion Date
January 31, 2013
Study Completion Date
January 31, 2013
NVA237 50 µg and indacaterol 150 µg
NVA237 50 µg and indacaterol 150 µg supplied as blistered capsules for inhalation.
Placebo to NVA237 and indacaterol 150 µg
Placebo to NVA237 and indacaterol 150 µg supplied as blistered capsules for inhalation.
Novartis Investigative Site, Sofia
Novartis Investigative Site, Budapest
Novartis Investigative Site, Brussels
Novartis Investigative Site, Brussels
Novartis Investigative Site, Budapest
Novartis Investigative Site, Luxembourg
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Gödöllő
Novartis Investigative Site, Herentals
Novartis Investigative Site, Turnhout
Novartis Investigative Site, Hasselt
Novartis Investigative Site, Genk
Novartis Investigative Site, Liège
Novartis Investigative Site, Plovdiv
Novartis Investigative Site, Malmedy/Bellevaux-Ligneuville
Novartis Investigative Site, Jambes
Novartis Investigative Site, Yvoir
Novartis Investigative Site, Pleven
Novartis Investigative Site, Stara Zagora
Novartis Investigative Site, Gosselies
Novartis Investigative Site, Gilly
Novartis Investigative Site, Montigny-le-Tilleul
Novartis Investigative Site, Deszk
Novartis Investigative Site, Rousse
Novartis Investigative Site, Varna
Novartis Investigative Site, Athens
Novartis Investigative Site, Salt
Novartis Investigative Site, Ponferrada
Novartis Investigative Site, Málaga
Novartis Investigative Site, Mersin
Novartis Investigative Site, Gijón
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Yenisehir/Izmir
Novartis Investigative Site, Torrelavega
Novartis Investigative Site, Kocaeli
Novartis Investigative Site, Illescas
Novartis Investigative Site, Moscow
Novartis Investigative Site, Saratov
Novartis Investigative Site, Nizhny Novgorod
Novartis Investigative Site, N.Novgorod
Novartis Investigative Site, Athens
Novartis Investigative Site, Athens
Novartis Investigative Site, Thessaloniki
Novartis Investigative Site, Érd
Novartis Investigative Site, Wilton
Novartis Investigative Site, Viladecans
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Southbourne
Novartis Investigative Site, Bardejov
Novartis Investigative Site, Bojnice
Novartis Investigative Site, Liptovský Hrádok
Novartis Investigative Site, Kráľovský Chlmec
Novartis Investigative Site, Námestovo
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Košice
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Centelles
Novartis Investigative Site, Sant Boi de Llobregat
Novartis Investigative Site, Mérida
Novartis Investigative Site, Ankara
Novartis Investigative Site, Burnhope
Novartis Investigative Site, Newcastle upon Tyne
Novartis Investigative Site, Alderton
Novartis Investigative Site, Cambridge
Novartis Investigative Site, Watford
Novartis Investigative Site, Atherstone
Novartis Investigative Site, Royal Leamington Spa
Novartis Investigative Site, Strensall
Novartis Investigative Site, Bath
Novartis Investigative Site, Bexhill-on-Sea
Novartis Investigative Site, Blackpool
Novartis Investigative Site, Bradford
Novartis Investigative Site, Chesterfield
Novartis Investigative Site, Huntingdon
Novartis Investigative Site, Manchester
Novartis Investigative Site, Newton Aycliffe
Novartis Investigative Site, Reading
Novartis Investigative Site, Telford
Novartis Investigative Site, Wiltshire
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY